More on vaccine efficacy trial
Smith, C.K.
Journal of the American Veterinary Medical Association 189(8): 854-856
1986
ISSN/ISBN: 0003-1488 PMID: 3771352 Document Number: 285910
Document emailed within 1 workday
Related Documents
Schmitt-Grohé, S.; Stehr, K.; Cherry, J.D.; Heininger, U.; Uberall, M.A.; Laussucq, S.; Eckhardt, T. 1997: Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group Developments in Biological Standardization 89: 113-118Wheeler, C.M.; Castellsagué, X.; Garland, S.M.; Szarewski, A.; Paavonen, J.; Naud, P.; Salmerón, J.; Chow, S.-N.; Apter, D.; Kitchener, H.; Teixeira, J.úl.C.; Skinner, S.R.; Jaisamrarn, U.; Limson, G.; Romanowski, B.; Aoki, F.Y.; Schwarz, T.F.; Poppe, W.A.J.; Bosch, F.X.; Harper, D.M.; Huh, W.; Hardt, K.; Zahaf, T.; Descamps, D.; Struyf, F.; Dubin, G.; Lehtinen, M.; Denham, I.; Garland, S.M.; Mindel, A.; O'Sullivan, M.; Skinner, S.R.; Waddell, R.; De Sutter, P.; Poppe, W.A.J.; Tjalma, W.; De Carvalho, N.S.; Naud, P.; Teixeira, J.C.; Aoki, F.Y.; Diaz-Mitoma, F.; Dionne, M.; Ferguson, L.; Miller, M.; Papp, K.; Ramjattan, B.; Romanowski, B.; Somani, R.; Apter, D.; Karppa, T.; Kudjoi, N.; Kyha-österlund, L.; Lehtinen, M.; Levanen, H.; Lönn 2012: Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial LANCET. Oncology 13(1): 100-110
De Bruyn, G.; Martinson, N.A.; Nkala, B.D.; Tshabangu, N.; Shilaluka, G.; Kublin, J.; Corey, L.; Gray, G.E. 2009: Uptake of male circumcision in an HIV vaccine efficacy trial Journal of Acquired Immune Deficiency Syndromes 51(1): 108-110
Gray, G.E.; Metch, B.; Churchyard, G.; Mlisana, K.; Nchabeleng, M.; Allen, M.; Moodie, Z.; Kublin, J.; Bekker, L.-G.; Alexander, S.; Corey, L.; Ducar, C.; Duerr, A.; Eaton, N.; McElrath, J.; Holt, R.ée.; Hural, J.; Kublin, J.; Wecker, M.; Escamilla, G.; Holman, D.; Metch, B.; Moodie, Z.; Self, S.; Allen, M.; Fix, A.; Follman, D.; Johnston, P.; Luzar, M.A.; Martinez, A.; Casimiro, D.; Isaacs, R.; Kierstead, L.; Leavitt, R.; Mehrotra, D.; Robertson, M.; DeBruyn, G.; Gray, G.; Nkala, B.; Magopane, T.; Mkhise, B.; Lehobye, I.; Mathebula, M.P.; Nchabeleng, M.; Bekker, L.-G.; Ronan, A.; Roux, S.; Mark, D.; Churchyard, G.; Latka, M.; Mngadi, C.L.-C.K.; Nielson, T.; Selepe, P.; Bennie, T.; Mlisana, K.; Naicker, N.; Puren, A.; Galetta, D.; Levendal 2013: Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa? Vaccine 31(16): 2089-2096
Coutinho, R.A.; Lelie, P.N.; Albrecht-van Lent, P.; Stoutjesdijk, L.; Huisman, J.; Kuipers, H.; Schut, L.J.; Reerink-Brongers, E.E.; Reesink, H.W.; van Aken, W.G. 1983: Efficacy trial of heat-inactivated hepatitis B vaccine (CLB) in male homosexuals in the Netherlands Developments in Biological Standardization 54: 287-292
Zaman, K.; Yunus, M.; El Arifeen, S.; Azim, T.; Faruque, A.S.G.; Huq, E.; Hossain, I.; Luby, S.P.; Victor, J.C.; Dallas, M.J.; Lewis, K.D.C.; Rivers, S.B.; Steele, A.D.; Neuzil, K.M.; Ciarlet, M.; Sack, D.A. 2012: Methodology and lessons-learned from the efficacy clinical trial of the pentavalent rotavirus vaccine in Bangladesh Vaccine 30(Suppl 1): A94-100
Whittle, H.; Jaffar, S.; Wansbrough, M.; Mendy, M.; Dumpis, U.; Collinson, A.; Hall, A. 2002: Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children BMJ 325(7364): 569
Zhu, F.-C.; Chen, W.; Hu, Y.-M.; Hong, Y.; Li, J.; Zhang, X.; Zhang, Y.-J.; Pan, Q.-J.; Zhao, F.-H.; Yu, J.-X.; Zhang, Y.-S.; Yang, X.; Zhang, C.-F.; Tang, H.; Zhang, H.; Lebacq, M.; David, M.-P.; Datta, S.K.; Struyf, F.; Bi, D.; Descamps, D. 2014: Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: results from a randomized controlled trial International Journal of Cancer 135(11): 2612-2622
Sirakov, M. 2012: Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial Akusherstvo i Ginekologiia 51(1): 63-64
Lehtinen, M.; Paavonen, J.; Wheeler, C.M.; Jaisamrarn, U.; Garland, S.M.; Castellsagué, X.; Skinner, S.R.; Apter, D.; Naud, P.; Salmerón, J.; Chow, S.-N.; Kitchener, H.; Teixeira, J.úl.C.; Hedrick, J.; Limson, G.; Szarewski, A.; Romanowski, B.; Aoki, F.Y.; Schwarz, T.F.; Poppe, W.A.J.; De Carvalho, N.S.; Germar, M.J.V.; Peters, K.; Mindel, A.; De Sutter, P.; Bosch, F.X.; David, M.-P.; Descamps, D.; Struyf, F.; Dubin, G.; Denham, I.; Garland, S.M.; Mindel, A.; O'Sullivan, M.; Skinner, S.R.; Waddell, R.; De Sutter, P.; Poppe, W.A.J.; Tjalma, W.; De Carvalho, N.S.; Naud, P.; Teixeira, J.C.; Aoki, F.Y.; Diaz-Mitoma, F.; Dionne, M.; Ferguson, L.; Miller, M.; Papp, K.; Ramjattan, B.; Romanowski, B.; Somani, R.; Apter, D.; Karppa, T.; Kudjoi, N 2012: Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial LANCET. Oncology 13(1): 89-99
Nosten, F.; Luxemburger, C.; Kyle, D.E.; Ballou, W.R.; Wittes, J.; Wah, E.; Chongsuphajaisiddhi, T.; Gordon, D.M.; White, N.J.; Sadoff, J.C.; Heppner, D.G. 1996: Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group Lancet 348(9029): 701-707
Villa, L.L.; Costa, R.L.R.; Petta, C.A.; Andrade, R.P.; Ault, K.A.; Giuliano, A.R.; Wheeler, C.M.; Koutsky, L.A.; Malm, C.; Lehtinen, M.; Skjeldestad, F.Egil.; Olsson, S-Eric.; Steinwall, M.; Brown, D.R.; Kurman, R.J.; Ronnett, B.M.; Stoler, M.H.; Ferenczy, A.; Harper, D.M.; Tamms, G.M.; Yu, J.; Lupinacci, L.; Railkar, R.; Taddeo, F.J.; Jansen, K.U.; Esser, M.T.; Sings, H.L.; Saah, A.J.; Barr, E. 2005: Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial Lancet. Oncology 6(5): 271-278
Wilhelmson, B. 1993: Trial and error for pertussis vaccine. Does the new recombinant vaccine have superior qualities? Lakartidningen 90(26-27): 2458-2459
Andrasik, M.P.; Sesay, F.Albertina.; Isaacs, A.; Oseso, L.; Allen, M. 2020: Social Impacts among Participants in HIV Vaccine Trial Network (HVTN) preventive HIV vaccine trials Journal of Acquired Immune Deficiency Syndromes 2020
Vaccari, M.; Poonam, P.; Franchini, G. 2010: Phase IIi HIV vaccine trial in Thailand: a step toward a protective vaccine for HIV Expert Review of Vaccines 9(9): 997-1005
Root, E.D.; Lucero, M.; Nohynek, H.; Anthamatten, P.; Thomas, D.S.K.; Tallo, V.; Tanskanen, A.; Quiambao, B.P.; Puumalainen, T.; Lupisan, S.P.; Ruutu, P.; Ladesma, E.; Williams, G.M.; Riley, I.; Simões, E.A.F. 2014: Distance to health services affects local-level vaccine efficacy for pneumococcal conjugate vaccine (PCV) among rural Filipino children Proceedings of the National Academy of Sciences of the United States of America 111(9): 3520-3525
Bakari, M.; Munseri, P.; Francis, J.; Aris, E.; Moshiro, C.; Siyame, D.; Janabi, M.; Ngatoluwa, M.; Aboud, S.; Lyamuya, E.; Sandström, E.; Mhalu, F. 2013: Experiences on recruitment and retention of volunteers in the first HIV vaccine trial in Dar es Salam, Tanzania - the phase I/Ii HIVIS 03 trial Bmc Public Health 13: 1149
Lindsey, J.C.; Shah, S.K.; Siberry, G.K.; Jean-Philippe, P.; Levin, M.J. 2013: Ethical tradeoffs in trial design: case study of an HPV vaccine trial in HIV-infected adolescent girls in lower income settings Developing World Bioethics 13(2): 95-104
Kintu, K.; Andrew, P.; Musoke, P.; Richardson, P.; Asiimwe-Kateera, B.; Nakyanzi, T.; Wang, L.; Fowler, M.G.; Emel, L.; Ou, S.-S.; Baglyos, L.; Gurunathan, S.; Zwerski, S.; Jackson, J.B.; Guay, L. 2013: Feasibility and safety of ALVAC-HIV vCP1521 vaccine in HIV-exposed infants in Uganda: results from the first HIV vaccine trial in infants in Africa Journal of Acquired Immune Deficiency Syndromes 63(1): 1-8
Friedman, A.J.; Wheeler, J. 1991: Efficacy and safety of ethynodiol diacetate 1 mg with ethynylestradiol 35 ug with an emphasis on contraceptive efficacy a phase iv trial Journal of Reproductive Medicine 36(4 Suppl): 328-333